Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Selective and accurate C5 acylcarnitine quantitation by UHPLC-MS/MS: Distinguishing true isovaleric acidemia from pivalate derived interference.

Minkler PE, Stoll MSK, Ingalls ST, Hoppel CL.

J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Sep 1;1061-1062:128-133. doi: 10.1016/j.jchromb.2017.07.018. Epub 2017 Jul 12.

PMID:
28734160
3.

Quantitative acylcarnitine determination by UHPLC-MS/MS--Going beyond tandem MS acylcarnitine "profiles".

Minkler PE, Stoll MS, Ingalls ST, Kerner J, Hoppel CL.

Mol Genet Metab. 2015 Dec;116(4):231-41. doi: 10.1016/j.ymgme.2015.10.002. Epub 2015 Oct 8.

4.

Validated method for the quantification of free and total carnitine, butyrobetaine, and acylcarnitines in biological samples.

Minkler PE, Stoll MS, Ingalls ST, Kerner J, Hoppel CL.

Anal Chem. 2015 Sep 1;87(17):8994-9001. doi: 10.1021/acs.analchem.5b02198. Epub 2015 Aug 13.

PMID:
26270397
5.

Management of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone-induced methemoglobinemia.

Kunos CA, Radivoyevitch T, Ingalls ST, Hoppel CL.

Future Oncol. 2012 Feb;8(2):145-50. doi: 10.2217/fon.11.147. Review.

6.

Preliminary clinical and pharmacologic investigation of photodynamic therapy with the silicon phthalocyanine photosensitizer pc 4 for primary or metastatic cutaneous cancers.

Kinsella TJ, Baron ED, Colussi VC, Cooper KD, Hoppel CL, Ingalls ST, Kenney ME, Li X, Oleinick NL, Stevens SR, Remick SC.

Front Oncol. 2011 Jun 30;1:14. doi: 10.3389/fonc.2011.00014. eCollection 2011.

7.

Quantification of carnitine and acylcarnitines in biological matrices by HPLC electrospray ionization-mass spectrometry.

Minkler PE, Stoll MS, Ingalls ST, Yang S, Kerner J, Hoppel CL.

Clin Chem. 2008 Sep;54(9):1451-62. doi: 10.1373/clinchem.2007.099226. Epub 2008 Aug 4.

8.

Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabine.

Krishnamurthi SS, Brell JM, Hoppel CL, Egorin MJ, Weaver KC, Li X, Ingalls ST, Zuhowski EG, Schluchter MD, Dowlati A, Cooney MM, Gibbons J, Overmoyer BA, Ivy SP, Remick SC.

Cancer Chemother Pharmacol. 2009 Feb;63(3):441-50. doi: 10.1007/s00280-008-0754-2. Epub 2008 Apr 15.

9.

Novel isolation procedure for short-, medium-, and long-chain acyl-coenzyme A esters from tissue.

Minkler PE, Kerner J, Ingalls ST, Hoppel CL.

Anal Biochem. 2008 May 15;376(2):275-6. doi: 10.1016/j.ab.2008.02.022. Epub 2008 Feb 29.

10.

Development of beta-lapachone prodrugs for therapy against human cancer cells with elevated NAD(P)H:quinone oxidoreductase 1 levels.

Reinicke KE, Bey EA, Bentle MS, Pink JJ, Ingalls ST, Hoppel CL, Misico RI, Arzac GM, Burton G, Bornmann WG, Sutton D, Gao J, Boothman DA.

Clin Cancer Res. 2005 Apr 15;11(8):3055-64.

11.
12.

A phase IB clinical and pharmacokinetic study of the angiogenesis inhibitor SU5416 and paclitaxel in recurrent or metastatic carcinoma of the head and neck.

Cooney MM, Tserng KY, Makar V, McPeak RJ, Ingalls ST, Dowlati A, Overmoyer B, McCrae K, Ksenich P, Lavertu P, Ivy P, Hoppel CL, Remick S.

Cancer Chemother Pharmacol. 2005 Mar;55(3):295-300. Epub 2004 Nov 6.

PMID:
15538570
13.

A phase I and pharmacodynamic study of fludarabine, carboplatin, and topotecan in patients with relapsed, refractory, or high-risk acute leukemia.

Cooper BW, Veal GJ, Radivoyevitch T, Tilby MJ, Meyerson HJ, Lazarus HM, Koc ON, Creger RJ, Pearson G, Nowell GM, Gosky D, Ingalls ST, Hoppel CL, Gerson SL.

Clin Cancer Res. 2004 Oct 15;10(20):6830-9.

14.

Pharmacokinetics of O6-benzylguanine (NSC637037) and its metabolite, 8-oxo-O6-benzylguanine.

Tserng KY, Ingalls ST, Boczko EM, Spiro TP, Li X, Majka S, Gerson SL, Willson JK, Hoppel CL.

J Clin Pharmacol. 2003 Aug;43(8):881-93.

PMID:
12953345
15.

A phase I and pharmacodynamic study of sequential topotecan and etoposide in patients with relapsed or refractory acute myelogenous and lymphoblastic leukemia.

Cooper BW, Donaher E, Lazarus HM, Green SB, Gosky DM, Rosenthal NS, Berger SJ, Li X, Ingalls ST, Hoppel CL, Gerson SL.

Leuk Res. 2003 Jan;27(1):35-44.

PMID:
12479850
16.

Phase I clinical and pharmacokinetic study of rebeccamycin analog NSC 655649 given daily for five consecutive days.

Dowlati A, Hoppel CL, Ingalls ST, Majka S, Li X, Sedransk N, Spiro T, Gerson SL, Ivy P, Remick SC.

J Clin Oncol. 2001 Apr 15;19(8):2309-18.

PMID:
11304785
17.

Phase II and pharmacokinetic/pharmacodynamic trial of sequential topoisomerase I and II inhibition with topotecan and etoposide in advanced non-small-cell lung cancer.

Dowlati A, Levitan N, Gordon NH, Hoppel CL, Gosky DM, Remick SC, Ingalls ST, Berger SJ, Berger NA.

Cancer Chemother Pharmacol. 2001;47(2):141-8.

PMID:
11269740
18.

A phase II and pharmacokinetic study of weekly 72-h topotecan infusion in patients with platinum-resistant and paclitaxel-resistant ovarian carcinoma.

Rose PG, Gordon NH, Fusco N, Fluellen L, Rodriguez M, Ingalls ST, Hoppel CL.

Gynecol Oncol. 2000 Aug;78(2):228-34.

PMID:
10926808
19.

O6-benzylguanine: a clinical trial establishing the biochemical modulatory dose in tumor tissue for alkyltransferase-directed DNA repair.

Spiro TP, Gerson SL, Liu L, Majka S, Haaga J, Hoppel CL, Ingalls ST, Pluda JM, Willson JK.

Cancer Res. 1999 May 15;59(10):2402-10.

20.

Simultaneous determination of O6-benzylguanine and 8-oxo-O6-benzylguanine in human plasma by reversed-phase high-performance liquid chromatography.

Stefan TL, Ingalls ST, Minkler PE, Willson JK, Gerson SL, Spiro TP, Hoppel CL.

J Chromatogr B Biomed Sci Appl. 1997 Dec 19;704(1-2):289-98.

PMID:
9518162
21.

Atypical urinary opiate excretion pattern.

Glass LR, Ingalls ST, Schilling CL, Hoppel CL.

J Anal Toxicol. 1997 Oct;21(6):509-14.

PMID:
9323535
22.

Determination of O6-benzylguanine in human plasma by reversed-phase high-performance liquid chromatography.

Stefan TL, Ingalls ST, Gerson SL, Willson JK, Hoppel CL.

J Chromatogr B Biomed Appl. 1996 Jun 7;681(2):331-8.

PMID:
8811444
23.
25.

Method for isolation of non-esterified fatty acids and several other classes of plasma lipids by column chromatography on silica gel.

Ingalls ST, Kriaris MS, Xu Y, DeWulf DW, Tserng KY, Hoppel CL.

J Chromatogr. 1993 Sep 8;619(1):9-19.

PMID:
8245168
26.
27.
28.

Determination of total carnitine in human urine by high-performance liquid chromatography.

Minkler PE, Ingalls ST, Hoppel CL.

J Chromatogr. 1987 Sep 25;420(2):385-93. No abstract available.

PMID:
3693509
29.

Rapid high-performance liquid chromatography of 3-methylhistidine in human urine.

Minkler PE, Ingalls ST, Griffin RL, Hoppel CL.

J Chromatogr. 1987 Jan 23;413:33-42.

PMID:
3558687
31.

Determination of carnitine, butyrobetaine, and betaine as 4'-bromophenacyl ester derivatives by high-performance liquid chromatography.

Minkler PE, Ingalls ST, Kormos LS, Weir DE, Hoppel CL.

J Chromatogr. 1984 Dec 12;336(2):271-83.

PMID:
6530459
32.
33.
34.

Rapid and sensitive method for the determination of salicylic acid in serum by reversed-phase ion-pair high-performance liquid chromatography.

Ingalls ST, Schwerkoske JF, Forman WB, Hoppel CL.

J Chromatogr. 1983 May 13;274:366-71. No abstract available.

PMID:
6874842
35.

Determination of 6-N-trimethyllysine in urine by high-performance liquid chromatography.

Hoppel CL, Weir DE, Gibbons AP, Ingalls ST, Brittain AT, Brown FM.

J Chromatogr. 1983 Jan 14;272(1):43-50.

PMID:
6404917
36.

Furosemide kinetics in patients with hepatic cirrhosis with ascites.

Fuller R, Hoppel C, Ingalls ST.

Clin Pharmacol Ther. 1981 Oct;30(4):461-7.

PMID:
7285480

Supplemental Content

Loading ...
Support Center